Transcranial direct current stimulation in the treatment of anxiety and depression in patients with oral cancer during perioperative period. Issue 35 (2nd September 2022)

• Record Type: Journal Article
• Authors: Gao, Zhi-biao; Zhang, Wen-juan; Tuo, Rui; Xiao, Xia; Cao, Wei-jing
• Is Part Of: Medicine. Volume 101:Issue 35(2022)
• Page Start: e30220
• Publication Date: 2022-09-02
• Subjects: anxiety -- depression -- efficacy -- oral cancer -- transcranial direct current stimulation; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000030220
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : This study retrospectively investigated the efficacy of transcranial direct current stimulation (tDCS) in the treatment of anxiety and depression in patients with oral cancer (OC) during the perioperative period (PPP). This retrospective study reviewed the electronic medical records of patients who underwent OC surgery and experienced anxiety and depression during PPP. The patients were divided into the treatment (n = 36) and control (n = 36) groups. The patients in the treatment group received tDCS, whereas those in the control group did not receive tDCS. The primary outcomes included the Self-rating Anxiety Scale (SAS) and the Self-rating Depression Scale (SDS). Secondary outcomes included adverse events (AEs). We analyzed the outcome data before and after treatment. After treatment, patients in the treatment group achieved greater relief in SAS ( P < .01) and SDS ( P < .01) scores than those in the control group. Regarding safety, no electronic medical records reported any AEs in this study. The results of this study showed that tDCS may help relieve depression and anxiety in patients with OC during PPP. However, high-quality prospective randomized controlled trials are required to confirm these findings.